Resumo
Definição
História e exame físico
Principais fatores diagnósticos
- cardiac disease
Outros fatores diagnósticos
- medications
- palpitations
- fatigue, weakness
- chest pain
- shortness of breath, cough
- nausea, vomiting
- lightheadedness, syncope
- rales
- edema
Fatores de risco
- substance misuse (alcohol ingestion/withdrawal, cocaine, amphetamines)
- digoxin toxicity
- previous cardiac surgery to correct congenital heart defects
- coronary artery disease
- exacerbation of chronic lung disease
- theophylline
Investigações diagnósticas
Primeiras investigações a serem solicitadas
- ECG
- digoxin level
- theophylline level
- CXR
- electrolytes
- toxicology screen
Investigações a serem consideradas
- vagal maneuvers, adenosine
- thyroid-stimulating hormone
- echocardiogram
- ambulatory 24-hour (Holter) ECG or event recorder
- electrophysiologic study (EPS)
Algoritmo de tratamento
adult: undifferentiated supraventricular tachycardia
adult: focal AT; digoxin excess not suspected
adult: focal AT; digoxin toxicity suspected
child
adult: sustained or recurrent focal AT
Colaboradores
Autores
Danesh Kella, MBBS, FHRS
Assistant Professor
Department of Cardiovascular Diseases
Division of Heart Rhythm
Mayo Clinic
Jacksonville
FL
Declarações
DK receives honoraria from Zoll Medical.
Agradecimentos
Dr Danesh Kella would like to gratefully acknowledge Dr Sarah Stahmer, previous contributor to this topic.
Revisores
Kathryn L. Berlacher, MD, MS
Assistant Professor and Cardiology Fellowship Program Director
University of Pittsburgh Medical Center
Pittsburgh
PA
Declarações
KLB declares that she has no competing interests.
Mehak Dhande, MD
Clinical Cardiac Electrophysiology Fellow
University of Pittsburgh Medical Center
Pittsburgh
PA
Declarações
MD declares that she has no competing interests.
Amal Mattu, MD
Associate Professor of Emergency Medicine
University of Maryland Medical Center
Baltimore
MD
Declarações
AM declares that he has no competing interests.
Vias Markides, MB(Hons), BS(Hons), MD, FRCP
Consultant Cardiologist
Royal Brompton & Harefield NHS Trust
Imperial College London
London
UK
Declarações
VM declares that he has no competing interests.
Referências
Principais artigos
Page RL, Joglar JA, Caldwell MA, et al. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2016 Apr 5;67(13):e27-e115.Texto completo Resumo
Brugada J, Katritsis DG, Arbelo E, et al. 2019 ESC guidelines for the management of patients with supraventricular tachycardia. The Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC). Eur Heart J. 2020 Feb 1;41(5):655-720.Texto completo Resumo
Artigos de referência
Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
Diagnósticos diferenciais
- Sinus tachycardia
- AV node re-entrant tachycardia
- AV re-entrant tachycardia or accessory pathway mediated tachycardia
Mais Diagnósticos diferenciaisDiretrizes
- JCS/JHRS 2020 guideline on pharmacotherapy of cardiac arrhythmias
- 2019 ESC guidelines for the management of patients with supraventricular tachycardia
Mais DiretrizesConectar-se ou assinar para acessar todo o BMJ Best Practice
O uso deste conteúdo está sujeito ao nosso aviso legal